Key Insights

Highlights

Success Rate

84% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

7.7%

4 terminated out of 52 trials

Success Rate

84.0%

-2.5% vs benchmark

Late-Stage Pipeline

10%

5 trials in Phase 3/4

Results Transparency

29%

6 of 21 completed with results

Key Signals

6 with results84% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (21)
P 1 (1)
P 2 (2)
P 3 (3)
P 4 (2)

Trial Status

Completed21
Unknown13
Recruiting8
Terminated4
Not Yet Recruiting4
Active Not Recruiting2

Trial Success Rate

84.0%

Benchmark: 86.5%

Based on 21 completed trials

Clinical Trials (52)

Showing 20 of 20 trials
NCT06174649Not ApplicableCompleted

Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial

NCT07407673Phase 3Not Yet Recruiting

Prediction and Prevention of Bloodstream Infections After Kidney Transplantation

NCT03226158Active Not RecruitingPrimary

Next Generation Pathogen Sequencing for Prediction of Adverse Events

NCT07372131Not ApplicableRecruitingPrimary

Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients

NCT07175116Not ApplicableCompleted

Advanced Dressings for CVC Infection Prevention in PICU

NCT06489535Not ApplicableCompleted

Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)

NCT07491419Not ApplicableRecruitingPrimary

The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)

NCT07593547RecruitingPrimary

Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections

NCT07601711Recruiting

Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort Study

NCT06069206Not ApplicableCompletedPrimary

Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes

NCT05210439Phase 4Active Not RecruitingPrimary

Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia

NCT07082322Not Yet RecruitingPrimary

European Prospective Bloodstream Infection Cohort

NCT06531031Not Yet RecruitingPrimary

Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples

NCT07004049Phase 4RecruitingPrimary

Optimising TREATment for Severe Gram-Negative Bacterial Infections

NCT06576258Not ApplicableRecruitingPrimary

The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia

NCT06624618Recruiting

Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit

NCT06271031Recruiting

Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection

NCT05210387Not ApplicableTerminated

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

NCT05411315Not ApplicableCompleted

Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment

NCT05270135Not ApplicableCompleted

ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs

Scroll to load more

Research Network

Activity Timeline